Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas

NCT01040559 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG: idarubicin

Sponsor

Centre Hospitalier Universitaire Dijon